You may have heard about the FDA’s landmark approval of Epidiolex, an epilepsy treatment which is over 98% cannabidiol (CBD). While CBD is a compound found in marijuana, it does not have psychoactive effects.
Since this approval, clinicians and patients have been asking great questions about how cannabidiol works to treat epilepsy and what risks may accompany its use.
An upcoming CURE webinar addresses the benefits and risks of using CBD to treat epilepsy. We’re excited to share what the latest research says and answer your questions about CBD and epilepsy. You can learn more about the webinar in this update. I hope you can join us to explore this fascinating topic.
Also in this update…
- A Free Webinar on The New Way to Describe Your Seizure Type
- Register Now for Day of Science in Los Angeles or Raleigh-Durham!
- CURE Champion Spotlight: How Erin Earnest Raised $73,000 for Epilepsy Research in Honor of Her Sister
- Secure Your Tickets to CURE’s 20th Annual Chicago Benefit on October 15
- Next CURE Events
I hope you’re having a great summer,
Laura S. Lubbers, PhD
Free Webinars on CBD & Epilepsy and The New Way to Describe Your Seizure Type
Curious how cannabidiol (CBD) can be harnessed to treat epilepsy? Discover what the latest research says in our upcoming webinar Cannabidiol and Epilepsy: The Real Risks and Benefits on Wednesday, October 24, at 1:00PM CT.
In this webinar, you will learn why CBD may be an effective treatment for certain types of epilepsy, the risks associated with CBD, and what the FDA approval of the CBD-based drug Epidiolex means for the future of epilepsy research and treatment.
Pediatric neurologist Anup D. Patel, MD, will lead the presentation and address your questions in a live Q&A.